Research Paper Volume 15, Issue 18 pp 9695—9717
Characterization of tumor microenvironment and sensitive chemotherapy drugs based on cuproptosis-related signatures in renal cell carcinoma
Figure 5. Analysis of immunity in RCC patients based on risk model. (A) Differential expression analysis of tumor microenvironment. (B) Differential expression analysis of tumor related score. (C) Differential expression analysis for the immune score of different immune cells and factors. (D) Differential expression analysis for the immune infiltration of different immune cells and factors. (E) Differential expression analysis for the immune checkpoint point genes between high- and low-risk score group. (F, G) Top 10 enriched GO (F) and KEGG terms (G). *p < 0.05. **p < 0.01. ***p < 0.001.